Top 10 search results for "Remicade" in Resources. To see all results and access other features, sign up for free.

... They found people were at greatest risk for developing demyelinating conditions such as MS, in which the immune system attacks the protective myelin sheath around nerves, leading to nerve damage​.The Risk Remains Small but Worth MonitoringHealthcare providers sometimes prescribe TNF inhibitors — such as golimumab (Simponi) and infliximab (Remicade) ...

... In one study of people with ankylosing spondylitis, the biologic drug infliximab (Remicade) — a tumor necrosis factor (TNF) inhibitor — improved anemia and hemoglobin levels, as well as physical function and fatigue. Another study compared TNF inhibitors with conventional antirheumatic drugs, such as methotrexate and sulfasalazine (Azulfidine). ...

... Common TNF inhibitor drugs include Humira (adalimumab) and Remicade (infliximab). Other biologic drugs include interleukin-17 inhibitors like Cosentyx (secukinumab). Talk With Others Who UnderstandMySpondylitisTeam is the social network for people with spondylitis and their loved ones. ...

... Food and Drug Administration (FDA) for treating spondylitis, and they can be administered by self-injection: Cimzia (a formulation of certolizumab pegol) Cosentyx (secukinumab) Enbrel (etanercept) Humira (adalimumab) Remicade (infliximab) Simponi (golimumab) Taltz (ixekizumab) Three main types of self-injection include prefilled syringes, self-injection ...

... TNF is a signaling protein involved in chronic inflammation.TNF-alpha inhibitors (also called TNF inhibitors or anti-TNF drugs) used in the treatment of axSpA include: Cimzia (certolizumab pegol) Enbrel (etanercept) Humira (adalimumab) Simponi (golimumab) Remicade (infliximab) Interleukins (ILs) are another type of protein involved in inflammation, ...

... treatment of axSpA has specific indications that determine whom it may be recommended for.Tumor Necrosis Factor-Alpha InhibitorsTumor necrosis factor-alpha (TNF-alpha) inhibitors available for subcutaneous injection include: Certolizumab pegol (sold as Cimzia) Etanercept (Enbrel) Adalimumab (Humira) Golimumab (Simponi) Another TNF inhibitor, infliximab (Remicade ...

... Types of TNF-alpha inhibitors include: Etanercept (Enbrel) Adalimumab (Humira) Infliximab (Remicade) Newer agents such as certolizumab pegol (Cimzia) and golimumab (Simponi) If TNF inhibitors don’t work, other biologic DMARDs can be used. Some of these target another molecule called interleukin-17 (IL-17). ...

... These include anti-tumor necrosis factor (TNF) drugs and interleukin (IL)-17 inhibitors such as: Cimzia (a formulation of certolizumab pegol) Cosentyx (secukinumab) Enbrel (etanercept) Humira (adalimumab) Remicade (infliximab) Simponi (golimumab) Taltz (ixekizumab) Learning more about self-injection may help you determine if this mode of treatment is ...

... Taking a TNF-alpha inhibitor reduces the inflammation caused by AS and halts disease activity, slowing the progress of joint damage and other symptoms of AS.TNF-alpha inhibitors include: Adalimumab (Humira) Certolizumab pegol (Cimzia)​​​​​​ Etanercept (Enbrel) Golimumab (Simponi) Infliximab (Remicade) These drugs are given either through self-injection ...

... Examples of TNF blockers include infliximab (Remicade), etanercept (Enbrel), and adalimumab (Humira). IL-17 inhibitors include secukinumab (Cosentyx) and ixekizumab (Taltz). Targeted synthetic therapy — These medications block specific factors causing inflammation. ...